<div id="readability-page-1"><div><p>Jiangsu Nhwa Pharmaceutical Co., LTD reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 4,470.99 million compared to CNY 4,145.46 million a year ago. Revenue was CNY 4,470.99 million compared to CNY 4,145.46 million a year ago.</p><p>Net income was CNY 1,106.05 million compared to CNY 1,020.11 million a year ago. Basic earnings per share from continuing operations was CNY 1.09 compared to CNY 1.01 a year ago. Diluted earnings per share from continuing operations was CNY 1.09 compared to CNY 1.01 a year ago.</p></div></div>

恩華藥業

<p>江蘇恩華藥業股份有限公司公佈了截至 2025 年 9 月 30 日的九個月財報。銷售額同比增長至 44.7099 億元人民幣，較去年同期的 41.4546 億元人民幣有所增加。淨收入上升至 11.0605 億元人民幣，相較於去年的 10.2011 億元人民幣。持續經營業務的基本和稀釋每股收益均為 1.09 元人民幣，較去年同期的 1.01 元人民幣有所上升</p>

江蘇恩華藥業股份有限公司公佈2025年9月30日止九個月的財務業績